Clinical case of the first covid-19 positive patient surviving mechanical ventilation
DOI:
https://doi.org/10.35381/s.v.v5i1.1608Keywords:
Coronavirus Infections, drug effects, rehabilitation. (Source, DeCS).Abstract
A clinical case is presented in the regional teaching hospital Ambato - Ecuador, where it is concluded that the use of conventional volume-controlled invasive mechanical ventilation, high-flow mask and pharmacological therapy, which are protocols proposed by the WHO, yielded encouraging results, mainly in young adult patients without pre-existing comorbidities, which presents a valid option for certain patients to overcome severe acute respiratory distress syndrome, which is the main characteristic in severe patients infected by the SARS COV-2 virus that triggers COVID-19. This together with the treatment plan that included; continuous hemodynamic monitoring, as well as analgesia, antibiotic therapy, COVID-19 prophylaxis protocol, and complementary laboratory tests helped for the optimal recovery of patient N/N who is one of the first cases that overcame invasive mechanical ventilatory therapy.
Downloads
References
Seyed Hosseini E, Riahi Kashani N, Nikzad H, Azadbakht J, Hassani Bafrani H, Haddad Kashani H. The novel coronavirus Disease-2019 (COVID-19): Mechanism of action, detection and recent therapeutic strategies. Virology. 2020;551:1-9. doi:10.1016/j.virol.2020.08.011
Castañón-González JA, Camacho-Juárez S, Gorordo-Delsol LA, et al. Simultaneous mechanical ventilation of several patients with a single ventilator. Ventilación mecánica simultánea con un solo ventilador a varios pacientes. Gac Med Mex. 2020;156(3):249-252. doi:10.24875/GMM.M20000379
Cinesi Gómez C, Peñuelas Rodríguez Ó, Luján Torné M, et al. Clinical consensus recommendations regarding non-invasive respiratory support in the adult patient with acute respiratory failure secondary to SARS-CoV-2 infection. Recomendaciones de consenso respecto al soporte respiratorio no invasivo en el paciente adulto con insuficiencia respiratoria aguda secundaria a infección por SARS-CoV-2. Med Intensiva (Engl Ed). 2020;44(7):429-438. doi:10.1016/j.medin.2020.03.005
González-Castro A, Fajardo Campoverde A, Medina A, Alapont VMI. Ventilación mecánica no invasiva y oxigenoterapia de alto flujo en la pandemia COVID-19: El valor de un empate [Non-invasive mechanical ventilation and high-flow oxygen therapy in the COVID-19 pandemic: the value of a draw]. Med Intensiva (Engl Ed). 2021;45(5):320-321. doi:10.1016/j.medin.2020.04.017
González-Castro A, Fajardo Campoverde A, Medina A, Modesto I Alapont V. Non-invasive mechanical ventilation and high-flow oxygen therapy in the COVID-19 pandemic: the value of a draw. Med Intensiva (Engl Ed). 2021;45(5):320-321. doi:10.1016/j.medine.2021.04.001
Moreno-González G, Mussetti A, Albasanz-Puig A, et al. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial. Trials. 2021;22(1):116. Published 2021 Feb 5. doi:10.1186/s13063-021-05072-4
Emadi A, Chua JV, Talwani R, Bentzen SM, Baddley J. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Trials. 2020;21(1):897. Published 2020 Oct 28. doi:10.1186/s13063-020-04819-9
Dioh W, Chabane M, Tourette C, et al. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial. Trials. 2021;22(1):42. Published 2021 Jan 11. doi:10.1186/s13063-020-04998-5
Payares-Herrera C, Martínez-Muñoz ME, Vallhonrat IL, et al. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial. Trials. 2021;22(1):9. Published 2021 Jan 6. doi:10.1186/s13063-020-04964-1
Gorman E, Millar J, McAuley D, O'Kane C. Mesenchymal stromal cells for acute respiratory distress syndrome (ARDS), sepsis, and COVID-19 infection: optimizing the therapeutic potential. Expert Rev Respir Med. 2021;15(3):301-324. doi:10.1080/17476348.2021.1848555
Hashemian SR, Aliannejad R, Zarrabi M, et al. Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series. Stem Cell Res Ther. 2021;12(1):91. Published 2021 Jan 29. doi:10.1186/s13287-021-02165-4
Lanzoni G, Linetsky E, Correa D, et al. Umbilical cord mesenchymal stem cells for COVID-19 acute respiratory distress syndrome: A double-blind, phase 1/2a, randomized controlled trial. Stem Cells Transl Med. 2021;10(5):660-673. doi:10.1002/sctm.20-0472
Kouroupis D, Lanzoni G, Linetsky E, et al. Umbilical Cord-derived Mesenchymal Stem Cells modulate TNF and soluble TNF Receptor 2 (sTNFR2) in COVID-19 ARDS patients. Eur Rev Med Pharmacol Sci. 2021;25(12):4435-4438. doi:10.26355/eurrev_202106_26156
Qin H, Zhao A. Mesenchymal stem cell therapy for acute respiratory distress syndrome: from basic to clinics. Protein Cell. 2020;11(10):707-722. doi:10.1007/s13238-020-00738-2
Kaye RJ. Overview of Stem Cell Therapy for Acute Respiratory Distress Syndrome with Focus on COVID 19. Pain Physician. 2020;23(4S):S421-S432.
Published
How to Cite
Issue
Section
License
CC BY-NC-SA : Esta licencia permite a los reutilizadores distribuir, remezclar, adaptar y construir sobre el material en cualquier medio o formato solo con fines no comerciales, y solo siempre y cuando se dé la atribución al creador. Si remezcla, adapta o construye sobre el material, debe licenciar el material modificado bajo términos idénticos.
OAI-PMH: https://fundacionkoinonia.com.ve/ojs/index.php/saludyvida/oai.
